A $64 million class action settlement recently approved by an Illinois judge means parents who bought their kids the antidepressant drug Paxil could be eligible to recoup their out-of-pocket expenses.
Paxil is said to have misled people about the medication’s safety. Parents of children who have taken the drug are trying to get reimbursements under a $64 million class-action deal. Although the money is helpful, parents feel that it can’t in any way replace their kids who have committed suicide. Under the deal, parents with proof that they bought GlaxoSmithKline PLC’s Paxil and Paxil CR, a controlled-release version of the drug, for their children are entitled to receive money. Parents who no longer have pharmacy records or receipts can get up to $100 refunded by signing a claim form that carries penalties for lying.
As most people would assume, GlaxoSmithKline denies that it promoted the drug to children while withholding information about negative side effects, including increased suicidal behavior. Anyone with a personal injury claim, including the parents of teenagers who took their own lives while taking Paxil, still can sue GlaxoSmithKline, as can insurers and governmental agencies who actually paid the bulk of the money. This has become a very serious issue and one that is tremendously hurting GlaxoSmithKline. Many of the patients were fortunate enough to not succeed in the suicidal attempts.
For more information on this subject, please refer to our section on Drugs, Medical Devices, and Implants.